Pfizer (PFE) Stock Value Declined While Kames Capital Plc Has Cut Its Stake; As Usa Compression Partners LP (USAC) Stock Declined, Holder Riverstone Holdings Has Raised Its Position

February 19, 2018 - By Marguerite Chambers

Riverstone Holdings Llc increased its stake in Usa Compression Partners Lp (USAC) by 1.86% based on its latest 2017Q3 regulatory filing with the SEC. Riverstone Holdings Llc bought 444,558 shares as the company’s stock declined 6.76% while stock markets rallied. The hedge fund held 24.33M shares of the public utilities company at the end of 2017Q3, valued at $406.76 million, up from 23.88M at the end of the previous reported quarter. Riverstone Holdings Llc who had been investing in Usa Compression Partners Lp for a number of months, seems to be bullish on the $1.13 billion market cap company. The stock increased 0.67% or $0.12 during the last trading session, reaching $17.99. About 144,714 shares traded. USA Compression Partners, LP (NYSE:USAC) has risen 15.40% since February 19, 2017 and is uptrending. It has underperformed by 1.30% the S&P500.

Kames Capital Plc decreased its stake in Pfizer Inc. (PFE) by 4.03% based on its latest 2017Q3 regulatory filing with the SEC. Kames Capital Plc sold 32,190 shares as the company’s stock declined 3.45% while stock markets rallied. The institutional investor held 765,654 shares of the health care company at the end of 2017Q3, valued at $27.32M, down from 797,844 at the end of the previous reported quarter. Kames Capital Plc who had been investing in Pfizer Inc. for a number of months, seems to be less bullish one the $216.14 billion market cap company. The stock increased 1.54% or $0.55 during the last trading session, reaching $36.26. About 26.24M shares traded or 24.01% up from the average. Pfizer Inc. (NYSE:PFE) has declined 2.76% since February 19, 2017 and is downtrending. It has underperformed by 19.46% the S&P500.

Investors sentiment decreased to 0.77 in Q3 2017. Its down 0.08, from 0.85 in 2017Q2. It turned negative, as 7 investors sold USAC shares while 19 reduced holdings. 6 funds opened positions while 14 raised stakes. 65.53 million shares or 1.37% more from 64.64 million shares in 2017Q2 were reported. Moreover, Arrow Investment Advsrs Ltd Liability Corp has 0.23% invested in USA Compression Partners, LP (NYSE:USAC) for 45,272 shares. Neuberger Berman Gru Limited Com stated it has 89,562 shares or 0% of all its holdings. Barclays Public Limited Liability Company accumulated 10,265 shares or 0% of the stock. Guggenheim Llc accumulated 107,267 shares or 0% of the stock. Pnc Financial Service Grp Inc stated it has 66,890 shares or 0% of all its holdings. Huntington Fincl Bank invested in 0% or 1,000 shares. Moreover, Rbf Cap Limited Liability has 0.04% invested in USA Compression Partners, LP (NYSE:USAC). Bard invested in 1.81% or 232,857 shares. Tennessee-based Ftb Advisors has invested 0% in USA Compression Partners, LP (NYSE:USAC). Citigroup Inc accumulated 36,760 shares. Jennison Assocs Ltd Llc holds 0.01% in USA Compression Partners, LP (NYSE:USAC) or 386,783 shares. Lucas owns 1.08% invested in USA Compression Partners, LP (NYSE:USAC) for 72,179 shares. Harvest Fund Ltd Limited Liability Company holds 0.39% or 2.25 million shares in its portfolio. 24.93 million are held by Carlyle Lp. Wealthtrust has 134 shares.

Among 8 analysts covering USA Compression Partners LP (NYSE:USAC), 3 have Buy rating, 2 Sell and 3 Hold. Therefore 38% are positive. USA Compression Partners LP had 28 analyst reports since July 28, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Sunday, July 30 by RBC Capital Markets. The stock of USA Compression Partners, LP (NYSE:USAC) has “Buy” rating given on Wednesday, January 17 by FBR Capital. Barclays Capital downgraded the stock to “Underweight” rating in Monday, January 11 report. The rating was maintained by RBC Capital Markets on Wednesday, August 23 with “Hold”. Goldman Sachs downgraded USA Compression Partners, LP (NYSE:USAC) rating on Tuesday, June 21. Goldman Sachs has “Sell” rating and $13 target. The firm earned “Hold” rating on Wednesday, January 17 by RBC Capital Markets. RBC Capital Markets downgraded it to “Sector Perform” rating and $20 target in Tuesday, February 14 report. Goldman Sachs maintained USA Compression Partners, LP (NYSE:USAC) rating on Thursday, May 12. Goldman Sachs has “Neutral” rating and $10 target. The firm earned “Outperform” rating on Friday, May 6 by RBC Capital Markets. As per Wednesday, November 8, the company rating was maintained by RBC Capital Markets.

Riverstone Holdings Llc, which manages about $23.60B and $2.85B US Long portfolio, decreased its stake in Pattern Energy Group Inc. (NASDAQ:PEGI) by 9.29 million shares to 7.68 million shares, valued at $185.02 million in 2017Q3, according to the filing.

Among 22 analysts covering Pfizer (NYSE:PFE), 10 have Buy rating, 1 Sell and 11 Hold. Therefore 45% are positive. Pfizer had 74 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Outperform” rating given on Thursday, October 19 by BMO Capital Markets. The rating was downgraded by Citigroup to “Sell” on Tuesday, May 16. Piper Jaffray maintained the stock with “Buy” rating in Tuesday, October 31 report. The stock of Pfizer Inc. (NYSE:PFE) earned “Buy” rating by UBS on Wednesday, November 1. Jefferies maintained Pfizer Inc. (NYSE:PFE) rating on Tuesday, September 13. Jefferies has “Buy” rating and $39 target. The firm has “Buy” rating given on Thursday, April 7 by Jefferies. Jefferies maintained the stock with “Hold” rating in Tuesday, January 16 report. Argus Research maintained the shares of PFE in report on Tuesday, November 3 with “Buy” rating. The firm has “Outperform” rating given on Monday, May 9 by Credit Suisse. SunTrust upgraded the stock to “Neutral” rating in Wednesday, November 25 report.

Kames Capital Plc, which manages about $3.65B US Long portfolio, upped its stake in Taiwan Semiconductor Manufac (NYSE:TSM) by 15,123 shares to 1.33 million shares, valued at $50.03M in 2017Q3, according to the filing. It also increased its holding in Bank Of America Corporation (NYSE:BAC) by 325,127 shares in the quarter, for a total of 2.31M shares, and has risen its stake in Digital Realty Trust Inc. (NYSE:DLR).

Investors sentiment increased to 0.96 in Q3 2017. Its up 0.02, from 0.94 in 2017Q2. It is positive, as 53 investors sold PFE shares while 700 reduced holdings. 106 funds opened positions while 620 raised stakes. 4.06 billion shares or 0.86% more from 4.02 billion shares in 2017Q2 were reported. Camarda Fin Advsrs Ltd Limited Liability Company holds 25,733 shares. Jones Companies Lllp reported 0.04% of its portfolio in Pfizer Inc. (NYSE:PFE). The Missouri-based Shelter Mutual Ins has invested 2.67% in Pfizer Inc. (NYSE:PFE). Bokf Na reported 0.58% stake. Wetherby Asset Mgmt reported 0.71% stake. Moreover, Td Asset Mgmt Inc has 0.41% invested in Pfizer Inc. (NYSE:PFE) for 7.59M shares. The South Carolina-based Verity And Verity Ltd has invested 2.2% in Pfizer Inc. (NYSE:PFE). Segment Wealth Mgmt Lc owns 137,239 shares. Magellan Asset Mgmt owns 810 shares. Mcrae Capital Mngmt reported 9,961 shares. Milestone Gp Incorporated holds 0.12% or 20,983 shares. Capital International holds 31.99 million shares or 1.37% of its portfolio. Conestoga Capital Advisors Ltd Liability Corporation has 17,635 shares for 0.03% of their portfolio. Suntrust Banks has 0.73% invested in Pfizer Inc. (NYSE:PFE) for 3.78M shares. Legacy Capital Prtnrs invested in 1.23% or 65,644 shares.

Since August 21, 2017, it had 0 insider purchases, and 7 selling transactions for $12.30 million activity. 8,064 shares were sold by OLSON LAURIE J, worth $263,693 on Monday, August 21. JOHNSON RADY A sold 8,000 shares worth $296,560. 94,409 shares were sold by DAMELIO FRANK A, worth $3.21M on Thursday, August 31. SUSMAN SALLY sold $1.34M worth of Pfizer Inc. (NYSE:PFE) on Tuesday, September 12. On Thursday, August 31 the insider READ IAN C sold $6.70 million.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: